Biotech AltPep scores around $53m in Series B funding round

Biotech AltPep scores around $53m in Series B funding round

Submitted by admin on June 23, 2023 - 9:56am
Source: 
Pharmaceutical Business Review
News Tags: 
AltPrep
funding
amyloid
Headline: 
Biotech AltPep scores around $53m in Series B funding round
snippet: 


US-based amyloid diseases treatment solutions developer AltPep has raised $52.9m in its Series B investment round led by Senator Investment Group.

Do Not Allow Advertisers to Use My Personal information